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S88 Inflammation and FibrosisResults: Numb is expressed in renal tubules and glomeruli. The expression of
Numb in renal tubules was significantly increased after UUO. After UUO,
PEPCK-Numb-KO mice exhibited significantly attenuated TIF. Ectopic expres-
sion of Numb increased the fraction of cells in G2/M stage and upregulated
the expression of TGF-b1 and CTGF in NRK52E cells. Knocking down endog-
enous Numb attenuated AA-induced G2/M arrest and profibrotic cytokines
production. Furthermore, G2/M arrest and expression of profibrotic cyto-
kines were significantly reduced in PEPCK-Numb-KO mice after UUO. Inhibit-
ing p53 activity dramatically mitigated Numb-induced G2/M arrest and
profibrotic cytokines production.
Conclusion: Numb has a profound effect on promoting G2/M arrest of TECs
through stabilizing p53 protein. Depletion of Numb markedly attenuates G2/
M arrest of proximal tubules which in turn reduces TIF. Numb might be a
novel therapeutic target for the treatment of tubulointerstitial fibrosis.http://dx.doi.org/10.1016/j.hkjn.2015.09.134
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Objective: Studies have shown that activation of peroxisome proliferator-
activated receptor-g (PPAR-g) ameliorates renal interstitial fibrosis (RIF) in
animal model. Yet, the underlying molecular mechanisms remain unknown.
Here, we investigated that activation of PPAR-g regulates renal remodeling
by modulating matrix metalloproteinases (MMPs) production in renal
fibroblasts.
Methods: In our present study, platelet-derived growth factor (PDGF) was
applied to stimulate renal fibroblasts, the inhibitor of PI3K or PTEN was
used to investigate the involvement of above mediators in MMPs production.
Results: Our results demonstrate that PDGF induced MMP2 secretion and this
effect was blocked by inhibition of PI3K. Pre-incubation of cells with rosigli-
tazone blocked PDGF-stimulated activation of AKT and PTEN and thus MMP2
production. Inhibition of PTEN by bpV (Pic) restored the suppression of PPAR-
g on AKT and MMP2.
Conclusion: Our results indicate that activation of PPAR-g inhibited MMP2
secretion by activation of PTEN and inactivation of AKT.http://dx.doi.org/10.1016/j.hkjn.2015.09.135
0349
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Background: Dyslipidemia is one of the risk factors contributing to the high
calcification burden in the arteries of CKD patients. However, the meta-
bolism by which lipids interact with mineral metabolism remains unknown.
We propose that Sterol Regulatory Element Binding Protein (SREBP) Cleavage
Activating Protein (SCAP), which is the central controller of lipid meta-
bolism, plays a role in VSMC calcification.
Methods: Calcium deposition was observed and colorimetrically analyzed by
Alizarin Red S staining and o-cresolphthalein complexone method. Theexpression of related genes and proteins were analyzed by real-time RT-
PCR and Western blotting methods. The co-expression of proteins was
observed by confocal microscope and flow cytometer. The influences of
calcifying medium and SCAP to VSMCs were investigated by TUNEL method,
wound scratch method and cell cycles analysis with PI staining.
Results: We demonstrated that phosphate markedly stimulated the
expression of SCAP in a dose dependent manner in human primary culture
of VSMC. We established a VSMC calcification model in vitro with 2.0 mM
phosphate and 2.7 mM calcium, in which SCAP expression was positively
associated with the expression of osteogenic marker/factor cbfa1. Over-
expression SCAP by pCMV-SCAP plasmid transfection led to more calcium
deposition, accompanying with up-regulated expression of osteogenic
markers cbfa1, BSP and ALP; and down-regulated expression of VSMC
maker a-SMA. These effects were blocked by knocking down SCAP by
applying siRNA against SCAP even in the presence of LPS which plays a
role as calcification inducer. Further, knocking-down SREBP2, a SCAP
target gene for lipid homeostasis did not affect SCAP induced calcium
deposition, suggesting that SCAP mediates phosphate induced vascular
calcification in a lipid independent pathway.
Conclusion: Our data strongly suggest that SCAP is a novel mediator of phos-
phate induced vascular calcification, and its pro-calcification effect is inde-
pendent of its traditional regulatory function in lipid metabolism.http://dx.doi.org/10.1016/j.hkjn.2015.09.136
0351
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Objective: To explore HIF-1 on anemia of the 5/6 nephrectomy kidney of
rats with chronic renal failure.
Methods: SD rats were divided randomly into three groups: control group;
model group; and EPO group. From the 3rd week the EPO group was injected
of recombinant human EPO 40 IU/Kg, biw. The animals were sacrificed after
3 months, collecting blood and tissue samples of residual kidney. Renal pa-
thology was observed by HE stain. We examined HIF-1 protein by immunoflu-
orescence and Western blotting.
Results: (1) The rats renal function. Compared with the control group,
there were no significant changes in renal function in the control group af-
ter injection of EPO. (2) The renal pathological changes in residual renal
tissue. There were no significant changes in tubules, glomeruli and renal
interstitial in the control group. It appears segmental glomerular scle-
rosis, focal renal interstitial fibrosis and epithelial atrophy in the model
group. There were no significant changes in the control group after injec-
tion of EPO. (3) The changes of anemia. Compared with the control group,
the Hb of model group dropped 11.3 0.52 g/L. However, after subcu-
taneous injection of EPO, anemia improved, namely Hb 12.55 0.53 g/l.
(4) HIF-1 expression. Compared with the control group, HIF-1 nucleus pos-
itive was 28 1.32 in model group, and HIF-1 main shrinking expansion of
renal tubular epithelial cells. After injection of EPO, the expression of
HIF-1 was reduced, that HIF-1 nucleus positive expression of 20 1.48
(P <0.05).
Conclusion: HIF-1 expression can improve renal anemia in rats with chronic
renal failure.
